Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Findings from Abraxis BioScience's phase 3 ABRAXANE trial in patients with NSCLC presented at ASCO

Abraxis BioScience, Inc. announced today that findings from their phase 3 randomized trial of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) plus carboplatin, showed a statistically significant 31 percent improvement in overall response rate when compared with Taxol (paclitaxel) injection plus carboplatin in the first-line treatment of patients with non-small cell lung cancer.

8 Jun 2010

Arrhythmia Alliance launches 'Know Your Pulse' global awareness campaign on World Heart Rhythm Week

Arrhythmia Alliance, the Heart Rhythm Charity, announced today the results of a survey conducted in Europe that showed a large number of respondents ignore basic measures to check for potential cardiac arrhythmias, or heart rhythm disorders. To raise awareness of the importance of pulse checking and to inform people about how to take their pulse, the Arrhythmia Alliance will open 2010 World Heart Rhythm Week (7-13 June) with the launch of the global awareness campaign 'Know Your Pulse'.

7 Jun 2010

Promising results of ABRAXANE for bladder cancer support efficacy of nab-driven chemotherapy

Abraxis BioScience, Inc. announced today that findings from a phase 1 randomized trial demonstrated that the nanoparticle albumin bound (nab®) driven chemotherapy, nab-paclitaxel (ABRAXANE® for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) is well-tolerated and active in the second-line treatment of high-grade, non-muscle-invasive bladder cancer that has been refractory to standard intra-bladder infusion (intravesical) therapy.

4 Jun 2010

High oxygen delivery after postcardiac arrest leads to higher rate of death in hospitals

Patients who have excessive oxygen levels in arterial blood (hyperoxia) following resuscitation from cardiac arrest have a higher rate of death in the hospital than similar patients without arterial hyperoxia, according to a study in the June 2 issue of JAMA.

2 Jun 2010

Odds of surviving cardiac arrest may depend on neighborhood: Study

The odds of surviving cardiac arrest may depend on which part of town you call home and whether anyone in the neighborhood comes to your rescue by attempting to perform cardiopulmonary resuscitation, according to a first-of-its-kind study in the June issue of the Annals of Internal Medicine.

1 Jun 2010

Weill Cornell Medical College commences construction of 18-story, $650 million Medical Research Building

Weill Cornell Medical College today celebrated the start of construction on its new Medical Research Building, a state-of-the-art facility that will more than double the institution's existing research space. The 18-story, $650 million building is the centerpiece of Weill Cornell's $1.3 billion Discoveries that Make a Difference Campaign, the country's largest for a medical college. A total of $1 billion has been raised toward this goal in a record time of less than four years.

27 May 2010

Half the high schools in Toronto do not train students how to perform CPR: Study

Almost half the high schools in Toronto do not teach students how to perform cardio-pulmonary resuscitation (CPR), even though it's part of the Grade 9 curriculum and studies have shown it can greatly increase the survival rates of people who suffer heart attacks outside of hospitals.

26 May 2010

Free emergency care training to address sudden cardiac arrest

The National Safety Council today announced it will offer free emergency care training during National CPR & AED Awareness Week (June 1-7). First Aid and CPR with AED is a three-hour online course that teaches participants how to respond should someone need assistance. First aid topics include breathing emergencies, sudden illness and injury, and bleeding.

26 May 2010

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Genzyme Corporation announced today that the FDA has granted U.S. marketing approval for Lumizyme™ (alglucosidase alfa), produced at the 4000 liter (L) bioreactor scale at its manufacturing facility in Geel, Belgium. Lumizyme is the first treatment approved in the United States specifically to treat patients with late-onset Pompe disease.

25 May 2010

Anaheim Regional Medical Center uses Arctic Sun cooling device to protect a patient from brain damage

A day after delivering her fourth child at Anaheim Regional Medical Center in Anaheim, California last December, 34-year-old Brynn Ervin suffered a cardiac arrest, the result of massive blood clots lodged in the main arteries that take blood to her lungs. Desperate to save the life of the young mother, the cardiac arrest team performed 95 minutes of CPR.

25 May 2010

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010

Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago.

21 May 2010

MHAUS to discuss how medical facilities can best prepare for MH emergency

Preparation is the best plan for Malignant Hyperthermia emergencies, and The Malignant Hyperthermia Association of the United States will be at the Ambulatory Surgery Center Annual Meeting, May 19-22, to answer questions about how medical facilities can best prepare for an MH emergency.

20 May 2010

Study results of Cameron Health's S-ICD- System published online in NEJM

Cameron Health, Inc. today announced the publication of study results online in the New England Journal of Medicine highlighting the development and potential benefits of the company's S-ICD- System, the first minimally invasive, subcutaneous implantable cardioverter defibrillator, for the treatment of sudden cardiac arrest.

14 May 2010

Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device

St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) of its AnalyST™ implantable cardioverter defibrillator (ICD) with ST Monitoring, a revolutionary device that not only provides life-saving therapy for dangerously fast heart rhythms, but also continuously monitors electrical changes (called ST segments) to help physicians monitor for cardiac problems.

12 May 2010

A 75 minute wait for ambulance costs life of a heart patient in North Queensland

On Monday a 44 year old man from Marian west of Mackay, called an ambulance after he developed heart problems. The paramedics reached his home more than an hour later to find him dead. The man called an ambulance at 1.31pm (AEST) on Monday but the Queensland Ambulance Service (QAS) said paramedics did not arrive until 2.46pm.

11 May 2010

Exposure to fine particulate matter can trigger cardiovascular deaths, heart attacks

The scientific evidence linking air pollution to heart attacks, strokes and cardiovascular death has "substantially strengthened," and people, particularly those at high cardiovascular risk, should limit their exposure, according to an updated American Heart Association scientific statement.

11 May 2010

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

A post-hoc analysis of a Phase 3 safety study demonstrated that NUCYNTA® (tapentadol) tablets were associated with a lower incidence of nausea, vomiting and constipation when compared to oxycodone immediate release (IR) tablets in elderly patients with moderate to severe low-back or osteoarthritis pain.

7 May 2010

Bill requiring AEDs be installed in public spaces will save countless lives across Ontario

A new provincial Bill undergoing second reading this week could have a profound effect on the outcomes of cardiac arrest and bystander CPR response in Ontario if it is passed.

6 May 2010

Forbidding ambulance costs deter heart attack victims from calling ‘000’: National Heart Foundation

According to a new survey conducted by The National Heart Foundation, the forbidding ambulance costs are preventing timely calls to the emergency by at least one in 10 heart attack victims. The Foundation also released a discussion paper released during Heart Week urging free universal ambulance services in all states and territories. Dr Bill Coote in the paper entitled Universal Ambulance Cover has also said that this would prevent many heart attack deaths.

5 May 2010

SonoSite, Physio-Control announce development collaboration for point-of-care ultrasound in EMS market

SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for the point-of-care, and Physio-Control, Inc., the global leader in the development and delivery of emergency medical response solutions, today announced a market development collaboration for point-of-care ultrasound in the emergency medical services (EMS) market. This alliance will enable SonoSite to expand its presence in the pre-hospital settings with the support of Physio-Control resources and extensive sales force.

3 May 2010

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Findings from Abraxis BioScience's phase 3 ABRAXANE trial in patients with NSCLC presented at ASCO

Arrhythmia Alliance launches 'Know Your Pulse' global awareness campaign on World Heart Rhythm Week

Promising results of ABRAXANE for bladder cancer support efficacy of nab-driven chemotherapy

High oxygen delivery after postcardiac arrest leads to higher rate of death in hospitals

Odds of surviving cardiac arrest may depend on neighborhood: Study

Weill Cornell Medical College commences construction of 18-story, $650 million Medical Research Building

Half the high schools in Toronto do not train students how to perform CPR: Study

Free emergency care training to address sudden cardiac arrest

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Anaheim Regional Medical Center uses Arctic Sun cooling device to protect a patient from brain damage

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010

MHAUS to discuss how medical facilities can best prepare for MH emergency

Study results of Cameron Health's S-ICD- System published online in NEJM

Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device

A 75 minute wait for ambulance costs life of a heart patient in North Queensland

Exposure to fine particulate matter can trigger cardiovascular deaths, heart attacks

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

Bill requiring AEDs be installed in public spaces will save countless lives across Ontario

Forbidding ambulance costs deter heart attack victims from calling ‘000’: National Heart Foundation

SonoSite, Physio-Control announce development collaboration for point-of-care ultrasound in EMS market

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in